Statements (11)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:developedBy |
gptkb:Morphic_Therapeutic
|
| https://www.w3.org/2000/01/rdf-schema#label |
MORF-057
|
| gptkbp:intendedIndication |
inflammatory bowel disease
|
| gptkbp:mechanismOfAction |
integrin inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:target |
αvβ8 integrin
|
| gptkbp:bfsParent |
gptkb:Morphic_Therapeutic
|
| gptkbp:bfsLayer |
6
|